Georgia's Online Cancer Information Center

Find A Doctor

Asad Bashey MD, PhD

Blood and Marrow Transplant Program at Northside Hospital Cancer Institute

Specialty and Certification

Medical Oncology / Board Certified

Clinical Trial Cancer Types

Hematologic Malignancies, Lymphoma, Multiple Myeloma, Multiple Primaries, Myelodysplastic Syndromes (MDS), Non-Hodgkin Lymphoma

Affiliations

Northside Hospital Cancer Center
Blood and Marrow Transplant Program at Northside Hospital

Active Clinical Trial Sites in Georgia

Blood and Marrow Transplant Program at Northside Hospital Cancer Institute

5670 Peachtree Dunwoody Road
Suite 1000
Atlanta, GA 30342
404-255-1930 (p)
www.bmtga.com

driving directions



Northside Hospital Cancer Institute

1000 Johnson Ferry Road NE
Atlanta, GA 30342
404-303-3355 (p)
www.northside.com

driving directions

Clinical Trials
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation and Marrow Toxic Injuries
Cancer Type: Hematologic Malignancies

A Phase 1, Multicenter, Open-Label Study of JCAR017, CD19-targeted Chimeric Antigen Receptor (CAR) T Cells, for Relapsed and Refractory (R / R) B-cell Non-Hodgkin Lymphoma (NHL)
Cancer Type: Lymphoma

A Global Randomized Multicenter Phase 3 Trial of JCAR017 Compared to Standard of Care in Adult Subjects With High-risk, Second-line, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas (TRANSFORM).
Cancer Type: Lymphoma

A Phase 1 Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351 (Daunorubicin and Cytarabine) Liposome for Injection Treatment in Adult Patients With Hematologic Malignancies
Cancer Type: Lymphoma

A Phase 3, Multicenter, Randomized, Open-label Study to Compare the Efficacy and Safety of bb2121 Versus Standard Triplet Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) (KarMMa-3)
Cancer Type: Lymphoma

A Phase 3, Multicenter, Randomized, Open-label Study to Compare the Efficacy and Safety of bb2121 Versus Standard Triplet Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM) (KarMMa-3)
Cancer Type: Multiple Myeloma

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
Cancer Type: Multiple Primaries

A Phase 1 Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351 (Daunorubicin and Cytarabine) Liposome for Injection Treatment in Adult Patients With Hematologic Malignancies
Cancer Type: Myelodysplastic Syndromes (MDS)

A Randomized Double-blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation versus Placebo in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
Cancer Type: Non-Hodgkin Lymphoma

A Phase 1, Multicenter, Open-Label Study of JCAR017, CD19-targeted Chimeric Antigen Receptor (CAR) T Cells, for Relapsed and Refractory (R / R) B-cell Non-Hodgkin Lymphoma (NHL)
Cancer Type: Non-Hodgkin Lymphoma
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.